On Invalid Date, Johnson & Johnson (NYSE: JNJ) reported Q2 2023 earnings per share (EPS) of $1.98, up 8.2% year over year. Total Johnson & Johnson earnings for the quarter were $5.14 billion. In the same quarter last year, Johnson & Johnson's earnings per share (EPS) was $1.83.
As of Q4 2023, Johnson & Johnson's earnings has grown -28.61% year over year. This is 21.29 percentage points lower than the US Drug Manufacturers - General industry earnings growth rate of -7.33%. Johnson & Johnson's earnings in the past year totalled $13.05 billion.
What is JNJ's earnings date?
Johnson & Johnson's earnings date is Invalid Date. Add JNJ to your watchlist to be reminded of JNJ's next earnings announcement.
What was JNJ's revenue last quarter?
On Invalid Date, Johnson & Johnson (NYSE: JNJ) reported Q2 2023 revenue of $25.53 billion up 6.29% year over year. In the same quarter last year, Johnson & Johnson's revenue was $24.02 billion.
What was JNJ's revenue growth in the past year?
As of Q4 2023, Johnson & Johnson's revenue has grown 2.29% year over year. This is 2.49 percentage points higher than the US Drug Manufacturers - General industry revenue growth rate of -0.2%. Johnson & Johnson's revenue in the past year totalled $97.77 billion.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.